Kengo Kidokoro

Okayama, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Finerenone Improves Albuminuria via MR-TRPC Signaling in Diabetic Kidney Disease.

Finerenone Improves Albuminuria via MR-TRPC Signaling in Diabetic Kidney Disease.

Journal: Hypertension (Dallas, Tex. : 1979)
Published: January 22, 2026

A GLP-1 receptor agonist enhances islet microvascular flow through nitric oxide-dependent mechanisms in a diabetic mouse model: investigation using intravital two-photon imaging.

A GLP-1 receptor agonist enhances islet microvascular flow through nitric oxide-dependent mechanisms in a diabetic mouse model: investigation using intravital two-photon imaging.

Journal: Diabetologia
Published: December 19, 2025

Endothelial dysfunction accelerates AKI-to-CKD transition by promoting β-catenin activation in macrophages.

Endothelial dysfunction accelerates AKI-to-CKD transition by promoting β-catenin activation in macrophages.

Journal: American journal of physiology. Renal physiology
Published: November 21, 2025

The Nonsteroidal Mineralocorticoid Receptor Blocker Esaxerenone reduces glomerular hyperfiltration and albuminuria.

The Nonsteroidal Mineralocorticoid Receptor Blocker Esaxerenone reduces glomerular hyperfiltration and albuminuria.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: November 09, 2025

Adenosine-mediated Neutrophil Regulation by Dapagliflozin Attenuates Renal Ischemia/Reperfusion Injury: Real-time Imaging and Metabolic Insights.

Adenosine-mediated Neutrophil Regulation by Dapagliflozin Attenuates Renal Ischemia/Reperfusion Injury: Real-time Imaging and Metabolic Insights.

Journal: Transplantation
Published: November 06, 2025

The non-steroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria.

The non-steroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 10, 2025

ASK-1 activation exacerbates kidney dysfunction via increment of glomerular permeability and accelerates cellular aging in diabetic kidney disease model mice.

ASK-1 activation exacerbates kidney dysfunction via increment of glomerular permeability and accelerates cellular aging in diabetic kidney disease model mice.

Journal: Scientific reports
Published: August 21, 2024

The Role of Mitochondria in Diabetic Kidney Disease and Potential Therapeutic Targets.

The Role of Mitochondria in Diabetic Kidney Disease and Potential Therapeutic Targets.

Journal: Kidney international reports
Published: July 30, 2024

Effects of Beraprost on Intestinal Microcirculation and Barrier Function in a Mouse Model of Renal Failure.

Effects of Beraprost on Intestinal Microcirculation and Barrier Function in a Mouse Model of Renal Failure.

Journal: Microcirculation (New York, N.Y. : 1994)
Published: March 06, 2024

Oxidative stress and the role of redox signalling in chronic kidney disease.

Oxidative stress and the role of redox signalling in chronic kidney disease.

Journal: Nature reviews. Nephrology
Published: September 20, 2023

Evaluation of glomerular hemodynamic changes by sodium-glucose-transporter 2 inhibition in type 2 diabetic rats using in vivo imaging.

Evaluation of glomerular hemodynamic changes by sodium-glucose-transporter 2 inhibition in type 2 diabetic rats using in vivo imaging.

Journal: Kidney international
Published: May 28, 2023

Insights into the Regulation of GFR by the Keap1-Nrf2 Pathway.

Insights into the Regulation of GFR by the Keap1-Nrf2 Pathway.

Journal: Kidney360
Published: August 09, 2022
Showing 1-12 of 32

Last Updated: 09/26/2026